Evidence map›Paper›PMID 42574714›Full record

ArticleJournal of investigative medicine high impact case reports

Malignancy in Disguise: Transudative Malignant Pleural Effusion from Early-Onset Lung Adenocarcinoma.

Ruba Habib, Rayan Sabouh, Rouba Isshak, Hala Moussa, Basel Aldroubi, George Horani, Ahmad Qatanani, Mourad Ismail

Abstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruba HabibDepartment of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0009-0009-6064-2869
Rayan SabouhDepartment of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Rouba IsshakDepartment of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0009-0006-7098-8538
Hala MoussaDepartment of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Basel AldroubiDepartment of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
George HoraniDepartment of Pulmonary and Critical Care Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0000-0003-1499-8126
Ahmad QatananiDepartment of Pulmonary and Critical Care Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Mourad IsmailDepartment of Pulmonary and Critical Care Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pleural effusions (MPEs) are almost always exudative, with only an estimated 3-4% meeting biochemical criteria for a transudate. Light's criteria remain the standard method for classifying pleural effusions, and transudative effusions typically do not undergo cytologic evaluation. This may delay the diagnosis of malignancy in rare cases where malignant cells are present in a biochemically transudative effusion. We present a 41-year-old homeless man with no established primary care who presented with progressive muscle cramping and was found to have severe electrolyte abnormalities, leukocytosis, and a right-sided pleural effusion with new bilateral pulmonary nodules on computed tomography. Pleural fluid analysis met clear transudative criteria by Light's criteria (protein ratio 0.24, LDH ratio 0.44). However, cytology revealed clusters of atypical cells consistent with pulmonary adenocarcinoma, confirmed by thyroid transcription factor-1 (TTF-1) positivity. The patient had no identifiable cause of transudative effusion, including heart failure, cirrhosis, nephrotic syndrome, or significant hypoalbuminemia. This case illustrates a rare presentation of malignant pleural effusion masquerading as a transudate in the absence of confounding systemic conditions. The mechanism likely involves early pleural metastatic involvement before the development of significant vascular permeability changes or lymphatic obstruction. This report underscores the importance of maintaining clinical suspicion for malignancy despite transudative biochemistry, particularly when features such as unilateral effusion, atypical imaging findings, or absence of an alternative systemic cause are present.

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsPleural Effusion, MalignantAdultDiagnosis, DifferentialExudates and TransudatesHumansMaleThyroid Nuclear Factor 1Tomography, X-Ray ComputedThyroid Nuclear Factor 1adenocarcinomaeffusionlung cancermalignancyNSCLCtransudative effusion

Identifiers

PMID42574714
PMCPMC13458127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.